Markel Group Inc. Has $21.42 Million Stock Position in HCA Healthcare, Inc. (NYSE:HCA)

Markel Group Inc. grew its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 9.6% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 62,001 shares of the company's stock after purchasing an additional 5,421 shares during the period. Markel Group Inc.'s holdings in HCA Healthcare were worth $21,424,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently modified their holdings of HCA. Pzena Investment Management LLC bought a new position in shares of HCA Healthcare during the first quarter worth about $39,445,000. Graypoint LLC grew its position in shares of HCA Healthcare by 3.0% during the first quarter. Graypoint LLC now owns 1,831 shares of the company's stock worth $633,000 after acquiring an additional 54 shares during the last quarter. Verdence Capital Advisors LLC grew its position in shares of HCA Healthcare by 4.9% during the first quarter. Verdence Capital Advisors LLC now owns 19,569 shares of the company's stock worth $6,762,000 after acquiring an additional 920 shares during the last quarter. Bridgewater Advisors Inc. bought a new position in HCA Healthcare in the 1st quarter valued at about $369,000. Finally, Larson Financial Group LLC grew its position in HCA Healthcare by 29.4% in the 1st quarter. Larson Financial Group LLC now owns 938 shares of the company's stock valued at $324,000 after buying an additional 213 shares in the last quarter. 62.73% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In other HCA Healthcare news, COO Jon M. Foster sold 15,698 shares of the stock in a transaction that occurred on Tuesday, May 13th. The stock was sold at an average price of $369.32, for a total transaction of $5,797,585.36. Following the transaction, the chief operating officer owned 12,646 shares in the company, valued at $4,670,420.72. This trade represents a 55.38% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. 1.30% of the stock is currently owned by company insiders.

HCA Healthcare Stock Down 0.5%

Shares of NYSE HCA traded down $1.69 during mid-day trading on Friday, reaching $360.91. The company had a trading volume of 1,029,847 shares, compared to its average volume of 1,452,207. The company has a market capitalization of $86.82 billion, a price-to-earnings ratio of 16.05, a PEG ratio of 1.27 and a beta of 1.47. The stock has a fifty day moving average of $376.24 and a two-hundred day moving average of $343.58. The company has a debt-to-equity ratio of 69.07, a quick ratio of 1.06 and a current ratio of 1.19. HCA Healthcare, Inc. has a 12-month low of $289.98 and a 12-month high of $417.14.

HCA Healthcare (NYSE:HCA - Get Free Report) last issued its quarterly earnings data on Friday, April 25th. The company reported $6.45 earnings per share for the quarter, beating the consensus estimate of $5.75 by $0.70. The firm had revenue of $18.32 billion for the quarter, compared to analyst estimates of $18.26 billion. HCA Healthcare had a net margin of 8.07% and a return on equity of 1,063.91%. The company's revenue for the quarter was up 5.7% on a year-over-year basis. During the same quarter last year, the firm earned $5.36 earnings per share. As a group, equities research analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, June 30th. Shareholders of record on Monday, June 16th were issued a dividend of $0.72 per share. The ex-dividend date of this dividend was Monday, June 16th. This represents a $2.88 annualized dividend and a yield of 0.80%. HCA Healthcare's dividend payout ratio (DPR) is presently 12.81%.

Wall Street Analysts Forecast Growth

HCA has been the subject of a number of recent analyst reports. Barclays set a $416.00 target price on shares of HCA Healthcare and gave the company an "overweight" rating in a research report on Monday, June 2nd. Robert W. Baird reiterated a "neutral" rating and issued a $336.00 target price (down previously from $396.00) on shares of HCA Healthcare in a research report on Tuesday, April 15th. Stephens upgraded shares of HCA Healthcare to a "strong-buy" rating in a research report on Monday, June 2nd. Baird R W lowered shares of HCA Healthcare from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, April 15th. Finally, Guggenheim started coverage on shares of HCA Healthcare in a research report on Wednesday, April 9th. They set a "neutral" rating for the company. Eight research analysts have rated the stock with a hold rating, ten have issued a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $399.21.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.